Johnston, Kimberly A.
Pino, Christopher J.
Chan, Goldia
Ketteler, Skylar K.
Goldstein, Stuart L.
Humes, H. David
Article History
Received: 4 October 2021
Revised: 1 March 2022
Accepted: 11 March 2022
First Online: 2 May 2022
Competing interests
: K.A.J., C.J.P., S.K.K., and H.D.H. are employees of Innovative BioTherapies (IBT). H.D.H. is a shareholder, an officer, and a director of IBT. K.A.J., C.J.P., and H.D.H. are shareholders of SeaStar Medical, Inc. C.J.P. and H.D.H. are inventors on patents held by SeaStar Medical. H.D.H. is a scientific advisor, a director, and a consultant to SeaStar Medical. S.L.G. receives consulting fees from SeaStar Medical. G.C. has no competing interests. SeaStar Medical was not involved in the execution of this study.
: No patient consent was required for this pre-clinical research study.